176 related articles for article (PubMed ID: 25995247)
1. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
[TBL] [Abstract][Full Text] [Related]
2. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.
Cai Z; Zhang C; Chang KS; Jiang J; Ahn BC; Wakita T; Liang TJ; Luo G
J Virol; 2005 Nov; 79(22):13963-73. PubMed ID: 16254332
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.
Foka P; Dimitriadis A; Karamichali E; Kyratzopoulou E; Giannimaras D; Koskinas J; Varaklioti A; Mamalaki A; Georgopoulou U
Virulence; 2016 Aug; 7(6):679-90. PubMed ID: 27058404
[TBL] [Abstract][Full Text] [Related]
4. How do persistent infections with hepatitis C virus cause liver cancer?
Mitchell JK; Lemon SM; McGivern DR
Curr Opin Virol; 2015 Oct; 14():101-8. PubMed ID: 26426687
[TBL] [Abstract][Full Text] [Related]
5. Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus.
Plissonnier ML; Lahlali T; Michelet M; Lebossé F; Cottarel J; Beer M; Neveu G; Durantel D; Bartosch B; Accardi R; Clément S; Paradisi A; Devouassoux-Shisheboran M; Einav S; Mehlen P; Zoulim F; Parent R
PLoS Biol; 2016 Mar; 14(3):e1002421. PubMed ID: 27031829
[TBL] [Abstract][Full Text] [Related]
6. It takes a team: a gain-of-function story of p53-R249S.
Wang H; Liao P; Zeng SX; Lu H
J Mol Cell Biol; 2019 Apr; 11(4):277-283. PubMed ID: 30608603
[TBL] [Abstract][Full Text] [Related]
7. RNA-binding proteins and exoribonucleases modulating miRNA in cancer: the enemy within.
Seo Y; Rhim J; Kim JH
Exp Mol Med; 2024 May; 56(5):1080-1106. PubMed ID: 38689093
[TBL] [Abstract][Full Text] [Related]
8. p53 destabilizing protein skews asymmetric division and enhances NOTCH activation to direct self-renewal of TICs.
Choi HY; Siddique HR; Zheng M; Kou Y; Yeh DW; Machida T; Chen CL; Uthaya Kumar DB; Punj V; Winer P; Pita A; Sher L; Tahara SM; Ray RB; Liang C; Chen L; Tsukamoto H; Machida K
Nat Commun; 2020 Jun; 11(1):3084. PubMed ID: 32555153
[TBL] [Abstract][Full Text] [Related]
9. The master regulator FUBP1: its emerging role in normal cell function and malignant development.
Debaize L; Troadec MB
Cell Mol Life Sci; 2019 Jan; 76(2):259-281. PubMed ID: 30343319
[TBL] [Abstract][Full Text] [Related]
10. Anticancer therapeutic strategies for targeting mutant p53-Y220C.
Chasov V; Davletshin D; Gilyazova E; Mirgayazova R; Kudriaeva A; Khadiullina R; Yuan Y; Bulatov E
J Biomed Res; 2024 May; 38(3):222-232. PubMed ID: 38738269
[TBL] [Abstract][Full Text] [Related]
11. Fructose-1,6-bisphosphatase 1 dephosphorylates and inhibits TERT for tumor suppression.
Li M; Wang Z; Tao J; Jiang H; Yang H; Guo D; Zhao H; He X; Luo S; Jiang X; Yuan L; Xiao L; He H; Yu R; Fang J; Liang T; Mao Z; Xu D; Lu Z
Nat Chem Biol; 2024 Mar; ():. PubMed ID: 38538923
[TBL] [Abstract][Full Text] [Related]
12. Reconnaissance of Allostery via the Restoration of Native p53 DNA-Binding Domain Dynamics in Y220C Mutant p53 Tumor Suppressor Protein.
Han ISM; Thayer KM
ACS Omega; 2024 May; 9(18):19837-19847. PubMed ID: 38737036
[TBL] [Abstract][Full Text] [Related]
13. The Role of p53 in HIV Infection.
Yaseen MM; Abuharfeil NM; Darmani H
Curr HIV/AIDS Rep; 2023 Dec; 20(6):419-427. PubMed ID: 38010468
[TBL] [Abstract][Full Text] [Related]
14. A Hill type equation can predict target gene expression driven by p53 pulsing.
Shi X
FEBS Open Bio; 2021 Jun; 11(6):1799-1808. PubMed ID: 33955710
[TBL] [Abstract][Full Text] [Related]
15. P53/NANOG balance; the leading switch between poorly to well differentiated status in liver cancer cells.
Ranjbar-Niavol F; Rezaei N; Zhao Y; Mirzaei H; Hassan M; Vosough M
Front Oncol; 2024; 14():1377761. PubMed ID: 38846985
[TBL] [Abstract][Full Text] [Related]
16. Correction for Dixit et al., "FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53".
Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
J Virol; 2017 Dec; 91(23):. PubMed ID: 29138336
[No Abstract] [Full Text] [Related]
17. Inhibition of microRNA-199a-5p reduces the replication of HCV via regulating the pro-survival pathway.
Wang H; Gao H; Duan S; Song X
Virus Res; 2015 Oct; 208():7-12. PubMed ID: 26027911
[TBL] [Abstract][Full Text] [Related]
18. A Proline-Tryptophan Turn in the Intrinsically Disordered Domain 2 of NS5A Protein Is Essential for Hepatitis C Virus RNA Replication.
Dujardin M; Madan V; Montserret R; Ahuja P; Huvent I; Launay H; Leroy A; Bartenschlager R; Penin F; Lippens G; Hanoulle X
J Biol Chem; 2015 Jul; 290(31):19104-20. PubMed ID: 26085105
[TBL] [Abstract][Full Text] [Related]
19. Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7.
Zhu B; Wei XX; Wang TB; Zhou YC; Liu AM; Zhang GW
Arch Virol; 2015 Aug; 160(8):2043-50. PubMed ID: 26071245
[TBL] [Abstract][Full Text] [Related]
20. LRRFIP1 Inhibits Hepatitis C Virus Replication by Inducing Type I Interferon in Hepatocytes.
Liu Y; Zou Z; Zhu B; Hu Z; Zeng P; Wu L
Hepat Mon; 2015 May; 15(5):e28473. PubMed ID: 26045710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
